Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting vascular endothelial growth factor using retinal gene therapy

15 Jun 2021

Abstract excerpt

Pharmacotherapies targeting vascular endothelial growth factor (VEGF) have revolutionized the management for neovascular retinal disorders including diabetic retinopathy and neovascular age-related macular degeneration. However, the burden of frequent injections, high cost, and treatment resistance in some patients remain unresolved. To overcome these challenges, newer generations of anti-angiogenic biological...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Retinal Development and Disorders
Share to Retinal Diseases and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34532414
DOI: 10.21037/atm-20-4417

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting vascular endothelial growth factor using retinal gene therapyPMID 34532414Read ↗

CRISPR Technology for Ocular AngiogenesisSemantic proximity Read ↗

Gene Therapy for Non-Hereditary Retinal Disease: Age-Related Macular Degeneration, Diabetic Retinopathy, and BeyondSemantic proximity Read ↗

Gene therapy for age-related macular degeneration: a promising frontier in vision preservationSemantic proximity Read ↗

AAV-Based Strategies for Treatment of Retinal and Choroidal Vascular Diseases: Advances in Age-Related Macular Degeneration and Diabetic Retinopathy TherapiesSemantic proximity Read ↗

Multiple gene therapy as a tool for regulating the expression of molecules involved in neovascular age-related macular degenerationSemantic proximity Read ↗

Gene Therapy Intervention in Neovascular Eye Disease: A Recent UpdateSemantic proximity Read ↗

Gene-Based Therapeutics for Acquired Retinal Disease: Opportunities and ProgressSemantic proximity Read ↗

Genome editing abrogates angiogenesis in vivoSemantic proximity Read ↗

Ocular Gene Therapy: A Literature Review With Focus on Current Clinical TrialsSemantic proximity Read ↗

Genome Editing VEGFA Prevents Corneal Neovascularization In VivoSemantic proximity Read ↗

Advancements in Neovascular Ophthalmopathy: Therapeutic Strategies and Future ProspectsSemantic proximity Read ↗

The Role of Gene Therapy in the Treatment of Retinal Diseases: A ReviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.